Sinuva Implant
Product Images NDC 10599-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sinuva (NDC 10599-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intersect Ent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sinuva 01)

Figure 1 (Sinuva 01)
An anatomical-style illustration showing an intrasinal implant labeled with parts including cap, short end, and long end. The dimensions marked are length and expanded diameter, demonstrating the implant's physical structure with multiple flexible legs extending outward.*
FDA Label Image

Figure 2 (Sinuva 02)

Figure 2 (Sinuva 02)
Illustration showing the internal view of the Sinuva implant device for intrasinal administration. The image displays the central structure and radiating supports inside the cylindrical implant, which is designed for placement within the sinus cavity.*
FDA Label Image

Figure 3 (Sinuva 03)

Figure 3 (Sinuva 03)
Illustration of the Sinuva implant delivery device showing labeled parts including the seeker, cup, long shaft, finger rests, and thumb rest. This device is used to insert the mometasone furoate implant intrasinally.*
FDA Label Image

Figure 4 (Sinuva 04)

Figure 4 (Sinuva 04)
An anatomical illustration showing a human hand holding a small cylindrical implant device, likely representing the Sinuva mometasone furoate 1350 ug intrasinal implant by Intersect ENT, Inc. The image highlights the size and shape of the implant relative to the hand.*
FDA Label Image

Figure 5 (Sinuva 05)

Figure 5 (Sinuva 05)
Illustration of the Sinuva implant delivery system, showing the device held in a hand with a close-up inset of the implant tip. The device is designed for intrasinal placement to deliver mometasone furoate, 1350 mcg, as an implant by Intersect ENT, Inc.*
FDA Label Image

Figure 6 (Sinuva 06)

Figure 6 (Sinuva 06)
Illustration depicting the Sinuva implant delivery device, a tool designed for intranasal placement of the mometasone furoate implant. The image shows a hand holding the device, featuring a long, flexible shaft with a control mechanism at the top. An inset image provides a close-up view of the implant portion attached to the device.*
FDA Label Image

Figure 7 (Sinuva 07)

Figure 7 (Sinuva 07)
An instructional diagram depicting the use of the Sinuva mometasone furoate 1350 ug/1 implant. The image shows a medical device being held and manipulated by a person's hands, illustrating the insertion or placement of the implant in the intranasal cavity, including a close-up view of the implant positioned within the sinus.*
FDA Label Image

Figure 8 (Sinuva 08)

Figure 8 (Sinuva 08)
An illustration showing the insertion of a medical implant device into a sinus cavity. The image depicts a hand holding a circular applicator device with a central implant being deployed into the sinus tissue using a slender tool, indicating placement within the intranasal area.*
FDA Label Image

Figure 9 (Sinuva 09)

Figure 9 (Sinuva 09)
Illustration showing a hand holding the Sinuva mometasone furoate intrasinal implant delivery device. The image depicts the application tool inserted into the implant, demonstrating placement within the nasal cavity.*
FDA Label Image

Figure 10 (Sinuva 10)

Figure 10 (Sinuva 10)
An illustration showing a hand holding a device to insert a Sinuva 1350 mcg mometasone furoate intranasal implant into the nasal cavity. The diagram visually demonstrates the implant placement process inside the sinus.*
FDA Label Image

Figure 11 (Sinuva 11)

Figure 11 (Sinuva 11)
An anatomical-style illustration showing the Sinuva implant device used for intranasal drug delivery. The implant features a segmented cylindrical body with a rounded tip and an open cage-like structure near the distal end, designed for placement inside the sinus cavity.*
FDA Label Image

Figure 12 (Sinuva 12)

Figure 12 (Sinuva 12)
An instructional illustration showing a hand holding an implant device designed for intrasinal administration. The image focuses on proper handling of the implant, which corresponds to Sinuva, a mometasone furoate intranasal implant.*
FDA Label Image

Figure 13 (Sinuva 13)

Figure 13 (Sinuva 13)
An instructional illustration shows a hand holding and positioning the Sinuva implant, a mometasone furoate 1350 mcg intrasinal implant, likely depicting the preparation or placement process. The implant and applicator device details are visible, indicating its intended use inside the nasal cavity.*
FDA Label Image

Figure 14 (Sinuva 14)

Figure 14 (Sinuva 14)
An instructional illustration showing a hand holding the Sinuva implant, a mometasone furoate 1350 microgram intrasinal implant by Intersect ENT, Inc. The image appears to demonstrate the handling or placement of the implant inside the nasal cavity.*
FDA Label Image

Figure 15 (Sinuva 15)

Figure 15 (Sinuva 15)
Illustration showing a top view of the Sinuva implant device, displaying the circular structure with multiple radial components inside, designed for intrasinal placement to deliver mometasone furoate.*
FDA Label Image

Chemical Structure (Sinuva 16)

Chemical Structure (Sinuva 16)
Chemical structure of mometasone furoate, the active ingredient in Sinuva implant. The diagram depicts the molecular structure with various rings, chlorine atoms, and functional groups characteristic of mometasone furoate.*
FDA Label Image

Principal Display Panel (1350 mcg Implant Pouch Carton)

Principal Display Panel (1350 mcg Implant Pouch Carton)
Label for Sinuva mometasone furoate sinus implant, 1350 mcg strength. The label states the implant is for single use only, sterile in unopened packaging, and intended for prescription use. It lists inactives including poly(DL-lactide-co-glycolide) and polyethylene glycol, and shows the NDC 10599-003-01. The labeler is Intersect ENT, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.